IP Litigation North America is where in-house patent and trade secret leaders come together to benchmark strategy, stress-test decisions, and stay ahead of fast-moving litigation risk across life sciences and technology.
Access in-house insight across patents and trade secrets: Learn directly from senior in-house IP and legal leaders across Pharma & Biotech, Tech & Innovation, and the dedicated Trade Secrets Track, sharing how they protect core assets, manage disputes, and mitigate risk across patents, confidential know-how, data, and proprietary technology.
Stay ahead of the issues shaping litigation strategy today: Dive into the most business-critical topics across three focused tracks. Explore preliminary injunctions, SPCs, biosimilars, and competition law within Pharma & Biotech; SEP/FRAND, interim licensing, AI, and UPC strategy in Tech & Innovation; and trade secret misappropriation, employee mobility, cross-border enforcement, and remedies within the Trade Secrets Track.
- Benchmark your approach against leading litigation expertise: Gain strategic perspective from top international and specialist firms contributing insights across patent and trade secret disputes, helping you compare tactics, assess risk, and understand how enforcement strategies differ across jurisdictions.
- Tailor your strategy by asset type, technology, and risk profile: Follow focused tracks covering MedTech, small molecules, large molecules, advanced technologies, and trade secrets, allowing you to prioritise the sessions most relevant to your products, data, and confidential assets.
- Hear directly from the institutions influencing outcomes: Receive first-hand updates from judicial and institutional voices, offering clarity on how courts and policymakers are approaching patent enforcement, competition issues, and trade secret protection—insight you can immediately apply to active and future disputes.